Clinical Trials Browser

Uterine Cervical Neoplasms × bemarituzumab × 1 year × Clear all

NCT07146919 2025-08-28

ANGELICA

Phase 1/2 Not yet recruiting

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms